Brookdale Senior Living Inc. (BKD)
Jordan R. Asher's term as a Board member expired on June 22, 2026, following his notice that he would not stand for re-election at the Annual Meeting.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Brookdale Senior Living Inc. (BKD)
Brookdale Senior Living held its Annual Meeting on June 22, 2026, with voting results on three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →Brookdale Senior Living Inc. (BKD)
Mark Fioravanti was appointed as Non-Executive Chairman of the Board effective immediately following the Annual Meeting on June 22, 2026, succeeding Denise W. Warren in the Chairman role.
View raw filing on EDGAR →MESOBLAST LTD (MEOBF)
Mesoblast announced a US$50 million drawdown from a five-year non-dilutive credit facility provided by shareholder Dr. Gregory George. This creates a new direct financial obligation with specified terms (8.00% fixed interest rate, five-year interest-only period, secured by Temcell royalty). The facility is material to the registrant's capital structure, explicitly described as strengthening the balance sheet and enabling retirement of higher-cost prior debt obligations.
View raw filing on EDGAR →Compass Group Diversified Holdings LLC
CODI entered into a Settlement Agreement and Mutual Release resolving all claims arising from Lugano Diamonds & Jewelry Inc.'s Chapter 11 bankruptcy proceedings and fraudulent actions by Lugano's former CEO. The settlement establishes a framework for CODI's recovery from the Lugano estate, including defined recovery rights (34.79% of inventory/tax/insurance proceeds, 45% of third-party litigation proceeds, 25% of other litigation claims), and accelerates resolution of the bankruptcy litigation.
View raw filing on EDGAR →TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
The exhibit discloses results of the 150th Annual General Meeting of Shareholders held on June 24, 2026, reporting shareholder approval of five proposals: appropriation of surplus (year-end dividend of 100 JPY per share), election of eight directors (including newly elected Julie Kim and Paul Stoffels), election of three audit and supervisory committee members (including newly elected Bruce Broussard and Koichiro Kimura), election of a substitute director, and approval of director bonuses. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, material to investors as it reflects governance changes and capital allocation decisions.
View raw filing on EDGAR →TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
The exhibit announces Julie Kim's appointment as Representative Director, President and CEO of Takeda following shareholder election and Board approval at the 150th Annual General Meeting. This is a material executive appointment of the company's chief executive officer, the most senior operational role. The disclosure also includes the concurrent retirement of former CEO Christophe Weber and appointments of three new external directors (Broussard, Kimura, Stoffels) and reassignments of existing directors to new committee roles, all effective June 24, 2026.
View raw filing on EDGAR →CorMedix Inc. (CRMD)
This is a classic Item 5.07 disclosure reporting the results of CorMedix's 2026 Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for eight proposals, including director elections, executive compensation advisory vote, auditor ratification, and multiple charter amendments. The disclosure of shareholder vote outcomes is material to investors as it reflects stockholder sentiment on governance, compensation, and corporate structure matters.
View raw filing on EDGAR →Bionano Genomics, Inc. (BNGO)
The filing discloses the appointment of Alex Hastie, Ph.D. as Chief Scientific Officer of Bionano Genomics, effective July 20, 2026. This is a material executive appointment to a senior leadership role responsible for leading the company's global scientific strategy, innovation roadmap, and research initiatives. The appointment is material because it involves a key executive position at a company in the genomics sector where scientific leadership directly impacts competitive positioning and product development strategy.
View raw filing on EDGAR →Phreesia, Inc. (PHR)
This 8-K Item 5.07 discloses the final voting results from Phreesia's annual meeting of stockholders held on June 24, 2026, covering three proposals: election of Class I directors (Chaim Indig and Jon Kessler), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure presents vote tallies (For, Against, Withheld, Abstentions, Broker Non-Votes) for each proposal, which is the core content of shareholder_vote_results.
View raw filing on EDGAR →Armour Residential REIT, Inc. (ARR-PC)
ARMOUR announced guidance on a monthly cash dividend of $0.24 per share payable to common stockholders for July 2026, with a record date of July 15, 2026 and payment date of July 30, 2026. This is a routine but material dividend declaration typical of REITs, which are required to distribute substantially all ordinary taxable income to maintain tax status. The disclosure clearly constitutes a dividend distribution event.
View raw filing on EDGAR →Comstock Inc. (LODE)
Comstock Inc. entered into a Securities Purchase Agreement on June 21, 2026, to sell 100% of its mineral, mining, processing, and related mining district entities (four subsidiaries) to Mackay Precious Metals Inc. for aggregate consideration exceeding $45 million in cash, stock, and contingent payments. This is a material disposition of substantially all of the Company's core mining assets, representing a fundamental transformation of the business as stated by the CEO: "transformation from a hard rock, junior mining company to our growing, global, renewable metals and materials company." The transaction qualifies as a material acquisition/disposition under Item 1.01.
View raw filing on EDGAR →Autonomix Medical, Inc. (AMIX)
Autonomix Medical implemented a 1-for-21 reverse stock split effective June 24, 2026, reducing outstanding shares from approximately 11.4 million to 543,000. The reverse split was approved by stockholders at the October 30, 2025 annual meeting and effected through an amendment to the certificate of incorporation filed with Delaware, materially affecting share ownership percentages, voting power, and trading mechanics.
View raw filing on EDGAR →CROWN CRAFTS INC (CRWS)
Crown Crafts issued a press release on June 24, 2026 announcing financial results for the fourth quarter and full year fiscal 2026 ended March 29, 2026. The disclosure includes net sales of $22.4 million for Q4 (vs. $23.2 million prior year), improved gross margin of 22.9% (vs. 18.3%), net income of $0.3 million (vs. net loss of $10.8 million), and full-year results with consolidated statements of operations and balance sheets. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and operational trends.
View raw filing on EDGAR →Picard Medical, Inc. (PMI)
Richard Fang, Ph.D. was appointed as Interim CEO effective June 18, 2026, following the planned departure of Patrick NJ Schnegelsberg. Dr. Fang will receive an annual salary of $400,000 and brings relevant executive experience to the role.
View raw filing on EDGAR →NextPlat Corp (NXPLW)
This is a clear disclosure of shareholder vote results from NextPlat's 2026 Annual Meeting held on June 24, 2026. The filing presents final voting tallies for four proposals: election of six directors, ratification of the independent auditor (RBSM LLP), advisory approval of named executive compensation, and adjournment authorization. All proposals passed with substantial majorities. This is a routine but material Item 5.07 disclosure required by SEC rules following any shareholder meeting.
View raw filing on EDGAR →ICF International, Inc. (ICFI)
ICF International announced the timing and details of its second quarter 2026 earnings release scheduled for August 6, 2026, after market close, along with a conference call to discuss financial results for the quarter ending June 30, 2026. This is a standard earnings announcement disclosure under Item 2.02, with the press release attached as Exhibit 99.1 providing webcast access and call details.
View raw filing on EDGAR →Beam Global (BEEM)
Beam Global entered into a material lease agreement for approximately 54,400 square feet of industrial space in Yuma, Arizona for office, warehouse, and manufacturing operations, with base rent escalating from $7,810.25 to $30,596.39 monthly and an embedded purchase option at $4.5 million.
View raw filing on EDGAR →BT Brands, Inc. (BTBDW)
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Shareholders held on June 19, 2026, reporting the election of four directors (Gary Copperud, Allan Anderson, Terri Tochihara-Dirks, and Fred Croci) with specific vote tallies for each nominee. The filing directly addresses Item 5.07 requirements and constitutes a material governance event affecting the composition of the board of directors.
View raw filing on EDGAR →UPEXI, INC. (UPXI)
On June 21, 2026, the Company entered into a Securities Purchase Agreement to issue approximately 12.2 million shares of common stock and pre-funded warrants in a private placement for approximately $19.5 million in aggregate consideration, with the proceeds used to retire existing debt. The securities were issued under Section 4(a)(2) and Regulation D exemptions to an accredited investor, substantially diluting existing shareholders and materially altering the capital structure.
View raw filing on EDGAR →Pulsenmore Ltd. (PLSM)
This exhibit announces a strategic partnership between Pulsenmore and Ouma Health to integrate Pulsenmore's FDA-authorized home ultrasound platform into Ouma's virtual maternity care model. The disclosure describes a material business development and partnership arrangement that expands Pulsenmore's presence in the U.S. maternal health market through an established virtual care provider serving expectant mothers nationwide. While not a traditional M&A transaction, this represents a significant operational and commercial milestone that would affect a reasonable investor's assessment of the company's market expansion strategy and revenue opportunities.
View raw filing on EDGAR →Jet.AI Inc. (JTAI)
The filing discloses a material acquisition transaction: Jet.AI Inc. entered into an Amended and Restated Agreement and Plan of Merger and Reorganization with flyExclusive, Inc., whereby Jet.AI will distribute SpinCo shares to stockholders and SpinCo will merge with flyExclusive's subsidiary. The filing reports on the stockholder vote status for this merger, with 688,430 shares (48.4% of outstanding) represented at the June 23 reconvened special meeting, approximately 99% voting in favor, but the meeting adjourned again to July 2, 2026 pending final approval. This is a change-of-control transaction requiring stockholder approval.
View raw filing on EDGAR →Cheche Group Inc. (CCGWW)
Cheche Group announces the launch of "Cheche Score," a proprietary AI-powered dynamic pricing model for NEV insurance. This is a material product launch and strategic business development—the company describes it as "a significant step forward in Cheche's strategy to redefine risk management" and notes it is "fully commercialized and functioning across multiple cities in China" with partnerships with major insurance carriers. While not a discrete M&A, governance, or financial event, this operational milestone would affect a reasonable investor's assessment of the company's competitive positioning and revenue-generation capability in its core NEV insurance market.
View raw filing on EDGAR →AMC Robotics Corp (AMCI)
AMC Robotics disclosed the signing of a lease agreement for a 6,150-square-meter manufacturing facility in Vietnam with planned investment of approximately $3.5 million to support production of its NovaArm™ robotic arm and future expansion. This is a material operational and strategic milestone—the transition from product development to manufacturing execution—but does not fit the specific categories of M&A activity, debt issuance, or other named event types. The disclosure is clearly operational in nature and material to investors assessing the company's commercialization progress and capital deployment.
View raw filing on EDGAR →Genenta Science S.p.A. (GNTA)
The 6-K discloses a Parachute Agreement (severance arrangement) entered into on June 19, 2026 between Genenta Science and Pierluigi Paracchi, the CEO and General Manager. The agreement specifies severance payments upon qualifying termination events (twelve months of gross remuneration plus target annual bonus up to 40% of annual gross remuneration), which constitutes a material compensatory arrangement for a named executive officer. While the filing also mentions an amendment to a non-compete covenant, the primary disclosure is the severance/parachute agreement, which falls squarely within executive compensation disclosures (Item 5.02(e) equivalent).
View raw filing on EDGAR →NextBoat Inc. (OTH)
The filing discloses post-acquisition integration progress following NextBoat's acquisition of Apex Marine Companies, completed on May 1, 2026. While the 8-K itself is filed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A item, the press release centers on material developments stemming from the acquisition: inventory integration, sales performance (15 vessels sold), service expansion, facility consolidation, and $90,000 in monthly cost savings. The acquisition itself is a material event that would affect a reasonable investor's assessment of the company's operations and financial position.
View raw filing on EDGAR →Massimo Group (MAMO)
Massimo Group entered into a loan agreement with its Executive Chairman David Shan on June 23, 2026, creating a new direct financial obligation of up to $4 million at 4% interest, repayable June 22, 2027. This is disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and represents the creation of a new debt obligation. While the lender is a controlling shareholder, the substance is a debt issuance that materially affects the company's capital structure and financial obligations.
View raw filing on EDGAR →Gamehaus Holdings Inc. (GMHS)
Gamehaus Holdings held an extraordinary general meeting of Class A shareholders to vote on amending the company's articles of association to increase the voting rights of Class B shares from 15 to 50 votes per share. The proposal would substantially increase Chairman Feng Xie's aggregate voting power from 76.7% to 91.3%, materially affecting the control structure and shareholder rights.
View raw filing on EDGAR →SKK Holdings Ltd (SKK)
This 6-K discloses the results of an extraordinary general meeting held on June 22, 2026, where shareholders voted on six resolutions. The primary material events are: (1) approval of an Asset Purchase Agreement to acquire Rantizo's drone-based technology assets for approximately $259.6 million in cash and stock (Resolution 1); (2) approval of a company name change to "Rantizo" (Resolution 2); and (3) approval of a 10x increase in authorized share capital (Resolution 3). All resolutions passed with overwhelming majorities. The disclosure of shareholder vote results on material transactions—particularly the acquisition and name change—is the core event type, though the filing also encompasses M&A activity approval and dilutive share issuance approval.
View raw filing on EDGAR →Rail Vision Ltd. (RVSNW)
Rail Vision announces successful completion of ShuntingYard field testing with Israel Railways and a non-binding MOU with Railserve (a Marmon Rail Company) to integrate its technology into Railserve's commercial railyard safety system. These represent material operational and commercial milestones—product validation and partnership expansion—that advance the company's commercialization trajectory, but do not constitute a discrete M&A transaction, earnings release, or other named event type. The disclosure emphasizes customer validation and market traction for an early-stage technology company.
View raw filing on EDGAR →Indaptus Therapeutics, Inc. (INDP)
The filing discloses a private placement of 20,000,000 shares of common stock at $0.60 per share, generating approximately $12,000,000 in gross proceeds. The shares were issued under Section 4(a)(2) of the Securities Act and Regulation S to non-U.S. accredited investors. This is a classic unregistered equity issuance (dilutive_issuance), disclosed under Items 1.01 and 3.02, representing a material capital raise for a small-cap company trading on Nasdaq Capital Market.
View raw filing on EDGAR →SHF Holdings, Inc. (SHFSW)
The filing discloses results of SHF Holdings' 2026 Annual Meeting of Stockholders held on June 17, 2026, under Item 5.07. The company reports voting outcomes for two matters: election of two Class II directors (Jonathon F. Niehaus and Sean Tonner) and ratification of Macias, Gini & O'Connell LLP as independent auditor for fiscal year 2026. All proposals were approved with required votes, making this a standard shareholder vote results disclosure.
View raw filing on EDGAR →Crypto Co (CRCW)
The Audit Committee concluded on June 24, 2026, that the Company's previously issued audited financial statements for fiscal year ended December 31, 2024, should no longer be relied upon due to an inadvertently failed recording of a $1,319,366 derivative liability related to convertible debt. The Company intends to correct this error by filing an amendment to the Original Filing, which is the hallmark of a financial restatement under Item 4.02.
View raw filing on EDGAR →DAXOR CORP (DXR)
The filing discloses Item 5.07 results from Daxor Corporation's Annual Meeting held June 23, 2026, including the election of six directors and ratification of Bush & Associates, CPA as the independent registered public accounting firm. The voting tallies for each director and the auditor ratification are explicitly provided, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →Currenc Group Inc. (CURR)
The exhibit discloses a "targeted operational restructuring" of the WalletKu subsidiary involving suspension of active business operations, "orderly workforce transitions," and allocation of up to US$150,000 for "employee severance liabilities." While the press release frames this as a strategic refocus on AI and Web3, the core disclosed action is an operational restructuring with associated workforce reduction and severance costs, which is the hallmark of a workforce_reduction event. The materiality is supported by the subsidiary's prior US$7.7M revenue and US$0.45M net loss, indicating a meaningful business segment being wound down.
View raw filing on EDGAR →Ming Shing Group Holdings Ltd (MSW)
The 6-K discloses results of an extraordinary general meeting held on June 16, 2026, where shareholders voted on and approved four resolutions. The resolutions include a significant share reorganization (increase of authorized capital from 100 million to 50 billion shares, redesignation into Class A and Class B shares with differential voting rights), and adoption of amended memorandum and articles of association. This is a classic shareholder vote results disclosure under Item 5.07, and the share reorganization with dual-class voting structure is material to investors' assessment of voting control and capital structure.
View raw filing on EDGAR →Alpha Star Acquisition Corp (ALSWF)
The filing discloses results of an Extraordinary General Meeting held on June 24, 2026, where shareholders voted on seven proposals, including approval of a Business Combination Agreement with XDATA, a Reincorporation Merger, Nasdaq listing compliance, governance amendments, an incentive plan, and director appointments. All proposals passed with overwhelming support (3,205,004 votes for, 0 against on most proposals). This is a classic Item 5.07 shareholder vote results disclosure, and the underlying business combination is material to investors.
View raw filing on EDGAR →Lucid Diagnostics Inc. (LUCD)
The filing discloses results of Lucid Diagnostics' annual stockholder meeting held on June 24, 2026, including: (1) election of three Class B directors (Cox, Palumbo, Sparks) with detailed vote tallies; (2) approval of an amendment to increase authorized common shares from 300 million to 400 million shares; and (3) ratification of CBIZ CPAs P.C. as independent auditor. Item 5.07 explicitly governs shareholder vote results, and the 100-million-share authorization increase is material to investors assessing dilution risk and capital-raising capacity.
View raw filing on EDGAR →PAVmed Inc. (PAVM)
PAVmed held its annual meeting of stockholders on June 24, 2026, at which shareholders elected two Class A directors (Ronald M. Sparks and Timothy Baxter), approved amendments to the Employee Stock Purchase Plan increasing available shares from 15,774 to 215,774, and ratified CBIZ CPAs P.C. as the independent auditor.
View raw filing on EDGAR →PARKS AMERICA, INC (PRKA)
The filing discloses a refinancing transaction (First Modification of Term Loan Agreement) on June 17, 2026, creating a new $2.33 million direct financial obligation with Cendera Bank maturing June 1, 2033. Although technically a modification of an existing loan, the 8-K Item 1.01 classification and the detailed disclosure of new material terms (interest rate structure, amortization, covenants, guaranty) indicate this is a material amendment creating substantively new debt obligations. The removal of the $2.5 million cash collateral reserve requirement and the interest rate swap arrangement further support materiality to investors.
View raw filing on EDGAR →Worksport Ltd (WKSP)
Worksport entered into two registered direct offerings on June 17–18, 2026, issuing 208,333 shares at $1.20 per unit (with warrants) and 675,529 shares at $0.70 per share, totaling approximately $722,870 in gross proceeds. The offerings include dilutive equity issuances and warrant grants with cashless exercise features, characteristic of a registered direct offering (PIPE-like structure). This is a material capital raise that dilutes existing shareholders and is disclosed under Item 1.01 (Entry into a Material Definitive Agreement).
View raw filing on EDGAR →SRX Global Inc. (SRXH)
Item 3.01 discloses that on March 23, 2026, NYSE American notified the Company it was not in compliance with continued listing standards under Section 1003(f)(v) due to stock price falling below $0.10, and trading was halted. The Company is undertaking a 1-for-60 reverse split to regain compliance. This is a classic delisting-risk disclosure—the exchange has notified the registrant of non-compliance and the registrant is taking corrective action to avoid delisting.
View raw filing on EDGAR →CEA Industries Inc. (BNCWW)
The filing discloses a Cooperation Agreement between CEA Industries and YZi Labs (a major shareholder holding 2.15M shares and warrants for 21.2M additional shares) that fundamentally restructures the company's governance. The agreement includes: (1) appointment of three YZi Labs directors (Ling Zhang, Alex Odagiu, Matthew Roszak) to expand the Board to six members; (2) formation of a CEO Search Committee to identify a new CEO by August 31, 2026; (3) appointment of Alex Odagiu as Interim President; (4) termination of YZi Labs' consent solicitation; and (5) customary standstill and voting agreements. While this involves multiple governance elements (director appointments, CEO search, board restructuring), the central event is a comprehensive governance settlement and board reconstitution driven by activist shareholder pressure, making it a material governance matter that does not fit neatly into the specific categories of exec_appointment or exec_departure alone.
View raw filing on EDGAR →Permex Petroleum Corp
The filing discloses a notice of acceleration and demand dated April 13, 2026, triggered by the Company's default on secured convertible debentures ($4.3M principal) issued November 1, 2024. The Company failed to make payments by November 2, 2025, and debenture holders have accelerated all sums due and initiated foreclosure proceedings on the Company's oil and gas leases in Martin County, Texas, scheduled for July 7, 2026. This is a classic covenant breach that accelerates a direct financial obligation and materially threatens the registrant's asset base and continued operations.
View raw filing on EDGAR →Nano Nuclear Energy Inc. (NNE)
Dr. Florent Heidet's employment and service as Chief Technology Officer and Head of Reactor Development was terminated effective June 22, 2026, with Board approval. While the filing also mentions James Walker's appointment as Interim Head of Reactor Development, the principal disclosed action centers on the departure of a named executive officer from a key technical leadership role at a nuclear technology company, making this primarily an exec_departure event.
View raw filing on EDGAR →Autozi Internet Technology (Global) Ltd. (AZI)
Autozi announced execution of a Securities Purchase Agreement under which it issued convertible promissory notes totaling $5.25 million in gross proceeds, with an additional $2.5 million option. The notes are convertible into Ordinary Shares at a conversion price based on closing sale price at time of conversion. This is a dilutive equity issuance offered under Section 4(a)(2) and Regulation D exemptions, materially affecting shareholder equity and ownership structure.
View raw filing on EDGAR →Prospect Floating Rate & Alternative Income Fund, Inc.
The filing discloses the Board of Directors' declaration of monthly "base" and quarterly "bonus" cash distributions to common shareholders of Prospect Floating Rate and Alternative Income Fund. The distributions are specified with record dates (June 26, 2026), payment dates (July 2, 2026), and per-share amounts ($0.02924 monthly base and $0.04723 quarterly bonus), representing a 14.96% annualized distribution rate. This is a routine but material dividend declaration typical of closed-end funds.
View raw filing on EDGAR →Oportun Financial Corp (OPRT)
This is a material governance agreement between Oportun and Bradley L. Radoff and The Radoff Family Foundation that involves board composition changes (two Class I directors retiring by the 2026 annual meeting), standstill restrictions limiting the Radoff Parties to 4.9% ownership, voting agreements tying the Radoff Parties' votes to Board recommendations, and mutual non-disparagement provisions through 2028. While the agreement contemplates director retirements, the central disclosed action is the entry into a comprehensive governance and standstill agreement that materially constrains a significant shareholder's actions and board influence, making it a governance matter broader than a simple executive departure or appointment.
View raw filing on EDGAR →BBCMS Mortgage Trust 2026-5C42
The filing discloses the issuance of BBCMS Mortgage Trust 2026-5C42 Commercial Mortgage Pass-Through Certificates with an aggregate principal amount of $570,184,000 in public certificates and additional private certificates sold to underwriters and initial purchasers. This represents creation of new direct financial obligations secured by 37 commercial and multifamily mortgage loans, fitting the debt_issuance category. While technically structured as mortgage-backed securities rather than traditional debt, the economic substance is the issuance of debt instruments backed by mortgage collateral.
View raw filing on EDGAR →Wells Fargo Commercial Mortgage Trust 2026-5C9
The filing discloses the issuance of Commercial Mortgage Pass-Through Certificates, Series 2026-5C9 pursuant to a Pooling and Servicing Agreement dated May 1, 2026. The Certificates represent beneficial ownership in a trust fund holding 29 fixed-rate mortgage loans and subordinate interests in commercial mortgage loans secured by 138 properties. This is a material securitization transaction creating direct financial obligations in the form of mortgage-backed securities, which falls squarely within debt_issuance.
View raw filing on EDGAR →